Ryan & Maniskas, LLP Announces Investigation of Ceradyne Inc.
October 02 2012 - 10:43AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/crdn) is
investigating potential claims against the board of directors of
Ceradyne Inc. (“Ceradyne” or the “Company”) (NASDAQ: CRDN)
concerning possible breaches of fiduciary duty and other violations
of law related to the Company’s efforts to sell the Company to 3M
Co. in an all-cash deal valued at approximately $860 million.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by the Company’s board of directors; in particular,
whether the Company undertook a fair process to obtain fair
consideration for all shareholders of Ceradyne. For more
information regarding our investigation, please contact Ryan &
Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877)
316-3218 or by email at rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/crdn
Under the terms of the proposed transaction, Ceradyne’s
stockholders will receive $35 in cash for each share of Ceradyne’s
common stock they own.
If you own shares of Ceradyne and would like to learn more about
these claims or if you wish to discuss these matters and have any
questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/crdn. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jul 2024 to Jul 2024
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jul 2023 to Jul 2024